MetLife Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Hold |
34,032
| – | – | 0.01% | 1244 |
|
|
2025
Q1 | $997K | Sell |
34,032
-547
| -2% | -$16K | 0.01% | 1366 |
|
|
2024
Q4 | $1.14M | Buy |
34,579
+1,916
| +6% | +$63K | 0.01% | 1345 |
|
|
2024
Q3 | $1.45M | Hold |
32,663
| – | – | 0.01% | 1183 |
|
|
2024
Q2 | $1.41M | Buy |
32,663
+3,600
| +12% | +$155K | 0.01% | 1156 |
|
|
2024
Q1 | $850K | Hold |
29,063
| – | – | 0.01% | 1391 |
|
|
2023
Q4 | $647K | Hold |
29,063
| – | – | ﹤0.01% | 1539 |
|
|
2023
Q3 | $719K | Hold |
29,063
| – | – | 0.01% | 1413 |
|
|
2023
Q2 | $823K | Buy |
29,063
+598
| +2% | +$16.9K | 0.01% | 1376 |
|
|
2023
Q1 | $654K | Hold |
28,465
| – | – | ﹤0.01% | 1476 |
|
|
2022
Q4 | $799K | Hold |
28,465
| – | – | 0.01% | 1327 |
|
|
2022
Q3 | $805K | Sell |
28,465
-1,922
| -6% | -$54.4K | 0.01% | 1304 |
|
|
2022
Q2 | $674K | Sell |
30,387
-1,660
| -5% | -$36.8K | 0.01% | 1456 |
|
|
2022
Q1 | $933K | Buy |
32,047
+11,726
| +58% | +$341K | 0.01% | 1379 |
|
|
2021
Q4 | $668K | Hold |
20,321
| – | – | 0.01% | 1333 |
|
|
2021
Q3 | $938K | Sell |
20,321
-1,793
| -8% | -$82.7K | 0.01% | 1144 |
|
|
2021
Q2 | $1.22M | Buy |
+22,114
| New | +$1.22M | 0.01% | 1068 |
|
|
2019
Q2 | – | Sell |
-69
| Closed | -$4.65K | – | 2426 |
|
|
2019
Q1 | $4.65K | Hold |
69
| – | – | ﹤0.01% | 2481 |
|
|
2018
Q4 | $3.18K | Hold |
69
| – | – | ﹤0.01% | 2511 |
|
|
2018
Q3 | $5.32K | Buy |
+69
| New | +$5.32K | ﹤0.01% | 2517 |
|